ACI’s Paragraph IV Disputes Conference

Topics

• Case Studies in New Ethical Developments Impacting Paragraph IV Practice

• The Dollars, Cents and Due Diligence of Pharmaceutical Patent Life Cycle Management and Litigation Planning: Brand-Name and Generic Perspectives
   

Event Details

ACI’s Paragraph IV Disputes conference enters its second decade this spring. In the course of this event’s tenure, we have witnessed the ongoing evolution of the Hatch-Waxman pharmaceutical patent endgame. The rules of this endgame have been reframed by the Medicare Modernization Act, America Invents Act, and to some extent the Affordable Care Act. There are now questions about where you can file suit and which forum to file in. There is still little clarity on how to settle one of these cases and not run the risk of government scrutiny despite a Supreme Court decision. 

Through this continuing evolution, each spring, Hatch-Waxman litigators, industry decision makers and stakeholders, Judges — now from two different forums — and government representatives will gather in New York City to attend this conference.
 
For more details about this event, please click here.